Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 438

1.

Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.

van den Brink EN, Ter Meulen J, Cox F, Jongeneelen MA, Thijsse A, Throsby M, Marissen WE, Rood PM, Bakker AB, Gelderblom HR, Martina BE, Osterhaus AD, Preiser W, Doerr HW, de Kruif J, Goudsmit J.

J Virol. 2005 Feb;79(3):1635-44.

2.

Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.

ter Meulen J, van den Brink EN, Poon LL, Marissen WE, Leung CS, Cox F, Cheung CY, Bakker AQ, Bogaards JA, van Deventer E, Preiser W, Doerr HW, Chow VT, de Kruif J, Peiris JS, Goudsmit J.

PLoS Med. 2006 Jul;3(7):e237.

3.

Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins.

Tripp RA, Haynes LM, Moore D, Anderson B, Tamin A, Harcourt BH, Jones LP, Yilla M, Babcock GJ, Greenough T, Ambrosino DM, Alvarez R, Callaway J, Cavitt S, Kamrud K, Alterson H, Smith J, Harcourt JL, Miao C, Razdan R, Comer JA, Rollin PE, Ksiazek TG, Sanchez A, Rota PA, Bellini WJ, Anderson LJ.

J Virol Methods. 2005 Sep;128(1-2):21-8.

PMID:
15885812
5.

Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).

Chou TH, Wang S, Sakhatskyy PV, Mboudjeka I, Lawrence JM, Huang S, Coley S, Yang B, Li J, Zhu Q, Lu S.

Virology. 2005 Mar 30;334(1):134-43. Erratum in: Virology. 2005 Jun 20;337(1):204. Mboudoudjeck, Innocent [corrected to Mboudjeka, Innocent].

6.

Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice.

Greenough TC, Babcock GJ, Roberts A, Hernandez HJ, Thomas WD Jr, Coccia JA, Graziano RF, Srinivasan M, Lowy I, Finberg RW, Subbarao K, Vogel L, Somasundaran M, Luzuriaga K, Sullivan JL, Ambrosino DM.

J Infect Dis. 2005 Feb 15;191(4):507-14.

8.

Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology.

Berry JD, Hay K, Rini JM, Yu M, Wang L, Plummer FA, Corbett CR, Andonov A.

MAbs. 2010 Jan-Feb;2(1):53-66.

10.

Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse.

Coughlin M, Lou G, Martinez O, Masterman SK, Olsen OA, Moksa AA, Farzan M, Babcook JS, Prabhakar BS.

Virology. 2007 Apr 25;361(1):93-102.

11.

SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity.

Liang MF, Du RL, Liu JZ, Li C, Zhang QF, Han LL, Yu JS, Duan SM, Wang XF, Wu KX, Xiong ZH, Jin Q, Li DX.

Biomed Environ Sci. 2005 Dec;18(6):363-74.

PMID:
16544518
12.
13.
14.

Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein.

Zhong L, Haynes L, Struble EB, Tamin A, Virata-Theimer ML, Zhang P.

Biochem Biophys Res Commun. 2009 Dec 18;390(3):1056-60. doi: 10.1016/j.bbrc.2009.10.115.

PMID:
19861118
15.

Characterization and epitope mapping of monoclonal antibodies to the nucleocapsid protein of severe acute respiratory syndrome coronavirus.

Kariwa H, Noda H, Nakauchi M, Ishizuka M, Hashiguchi K, Hashimoto S, Yoshii K, Asano A, Agui T, Kogaki H, Kurano Y, Uchida Y, Fujii N, Okada M, Takashima I.

Jpn J Vet Res. 2008 Feb;55(4):115-27.

PMID:
18380153
16.

Chicken single-chain variable fragments against the SARS-CoV spike protein.

Lee YC, Leu SJ, Hu CJ, Shih NY, Huang IJ, Wu HH, Hsieh WS, Chiang BL, Chiu WT, Yang YY.

J Virol Methods. 2007 Dec;146(1-2):104-11.

PMID:
17643500
17.
18.

Production of a monoclonal antibody against SARS-CoV spike protein with single intrasplenic immunization of plasmid DNA.

Yu XF, Liang LH, She M, Liao XL, Gu J, Li YH, Han ZC.

Immunol Lett. 2005 Sep 15;100(2):177-81.

PMID:
15893826
19.

An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.

Zhou T, Wang H, Luo D, Rowe T, Wang Z, Hogan RJ, Qiu S, Bunzel RJ, Huang G, Mishra V, Voss TG, Kimberly R, Luo M.

J Virol. 2004 Jul;78(13):7217-26.

20.

Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus.

Berry JD, Jones S, Drebot MA, Andonov A, Sabara M, Yuan XY, Weingartl H, Fernando L, Marszal P, Gren J, Nicolas B, Andonova M, Ranada F, Gubbins MJ, Ball TB, Kitching P, Li Y, Kabani A, Plummer F.

J Virol Methods. 2004 Sep 1;120(1):87-96.

PMID:
15234813
Items per page

Supplemental Content

Support Center